|本期目录/Table of Contents|

[1]刘卫明,齐建雄,孙妙艳,等.有创-无创序贯机械通气联合纳美芬治疗重度Ⅱ型呼吸衰竭临床分析[J].中华肺部疾病杂志,2020,(06):773-776.[doi:10.3877/cma.j.issn.1674-6902.2020.06.012]
　Liu Weiming,Qi Jianxiong,Sun Miaoyan,et al.Clinical analysis of invasive-noninvasive sequential mechanical ventilation combined with nalmefene in the treatment of severe type Ⅱ respiratory failure[J].,2020,(06):773-776.[doi:10.3877/cma.j.issn.1674-6902.2020.06.012]
点击复制

有创-无创序贯机械通气联合纳美芬治疗重度Ⅱ型呼吸衰竭临床分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2020年06期
页码:
773-776
栏目:
论著
出版日期:
2020-12-20

文章信息/Info

Title:
Clinical analysis of invasive-noninvasive sequential mechanical ventilation combined with nalmefene in the treatment of severe type Ⅱ respiratory failure
作者:
刘卫明; 齐建雄; 孙妙艳; 金同新; 林燕梅; 罗德成
523770 东莞市大朗医院重症医学科
Author(s):
Liu Weiming;  Qi Jianxiong;  Sun Miaoyan;  Jin Tongxin;  Lin Yanmei;  Luo Decheng.
Department of Critical Care Medicine, Dalang Hospital, Dongguan 523770 China
关键词:
有创-无创序贯机械通气;  纳美芬;  重度Ⅱ型呼吸衰竭;  血气指标
Keywords:
Invasive-non-invasive sequential mechanical ventilation;  Nalmefene;  Severe type Ⅱ respiratory failure;  Blood gas index
分类号:
-
DOI:
10.3877/cma.j.issn.1674-6902.2020.06.012
摘要:
目的 探讨有创-无创序贯机械通气联合纳美芬治疗重度Ⅱ型呼吸衰竭临床效果。方法 选取2018年10月至2020年2月我院诊治60例重度Ⅱ型呼吸衰竭患者,将患者用随机分为常规组28例(有创-无创序贯机械通气治疗)和研究组32例(有创-无创序贯机械通气治疗联合纳美芬治疗)。比较两组患者血气水平、神经功能损伤情况、生命体征、有创通气治疗时间、ICU住院时间和总住院时间,及相关并发症发生率。结果(1)组内比较,两组治疗前、治疗1、3、5 d的氧分压(PaO2)水平、酸碱度(pH)值、GCS评分、动脉收缩压升高,二氧化碳分压(PaCO2)水平、自主呼吸频率、心率均降低(P<0.05)。组间比较,两组治疗前血气分析指标、GCS评分、自主呼吸频率、心率及动脉收缩压均无明显差异(P>0.05); 研究组治疗1、3、5 d的PaO2水平、GCS评分、动脉收缩压高于常规组,PaCO2水平、自主呼吸频率、心率低于常规组(P<0.05); 两组治疗1、3、5 d的pH值无明显差异(P>0.05);(2)研究组有创通气时间、总机械通气时间、住重症监护室时间、总住院时间低于常规组(P<0.05);(3)研究组VAP发生率、再插管率发生率均低于常规组(3.57% vs. 28.13%,0.00% vs. 18.75%),P<0.05。结论 有创-无创序贯机械通气联合纳美芬治疗重度Ⅱ型呼吸衰竭,具有显著临床疗效。
Abstract:
Objective To investigate the clinical effects of invasive-non-invasive sequential mechanical ventilation combined with nalmefene in the treatment of severe type Ⅱ respiratory failure. Methods Selected from 2018-10-2020-02 in our hospital to diagnose and treat 60 cases of severe type Ⅱ respiratory failure to implement research, Use the randomized grouping table to divide into the conventional group(invasive-noninvasive sequential mechanical ventilation treatment, 28 cases)and the research group(invasive-noninvasive sequential mechanical ventilation treatment combined with nalmefene treatment, 32 cases). The blood gas levels, neurological damage, vital signs, invasive ventilation treatment time, ICU hospital stay and total hospital stay, and the incidence of related complications were compared between the two groups. Results(1)Comparison of PaO2(oxygen partial pressure)level, pH(pH)value, GCS score, arterial systolic blood pressure, and PaCO2(carbon dioxide partial pressure)before treatment, 1 day, 3 days, and 5 days after treatment. Level, spontaneous respiratory rate, and heart rate were all decreased(P<0.05). There were no significant differences in blood gas analysis index, GCS score, spontaneous respiratory rate, heart rate and arterial systolic pressure between the two groups before treatment(P>0.05). The PaO2 level, GCS score, and arteries of the experimental group at 1 d, 3 d, and 5 d were treated. The systolic blood pressure was higher than that of the control group, PaCO2 level, spontaneous respiratory rate and heart rate were lower than the control group(P<0.05). There was no significant difference in pH value between the two groups at 1 d, 3 d and 5 d(P>0.05).(2)The study group's invasive ventilation time, total mechanical ventilation time, stay in intensive care unit, and total hospital stay were lower than those in the conventional group(P<0.05).(3)The incidence of VAP and reintubation in the study group were lower than those in the conventional group [3.57% vs. 28.13%, 0.00% vs. 18.75%, P<0.05]. Conclusion Invasive-noninvasive sequential mechanical ventilation combined with nalmefene in the treatment of severe type Ⅱ respiratory failure has significant clinical effects.

参考文献/References:

1 胡泽福. 无创机械通气治疗慢性阻塞性肺疾病急性加重伴Ⅱ型呼吸衰竭的临床效果观察[J]. 实用心脑肺血管病杂志, 2015, 23(1): 90-91.
2 冯 力. 老年急性呼吸衰竭患者治疗中无创呼吸机辅助治疗价值分析[J]. 河北医药, 2018, 40(5): 714-717.
3 Barrio P, Ortega L, Guardia J, et al. Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results[J]. Clin Drug Investig, 2018, 38(2): 147-155.
4 Palpacuer C, Duprez R, Huneau A, et al. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate[J]. Addiction, 2018, 113(2): 220-237.
5 张新超, 于学忠. 学习与运用欧美学术理论要同中国的临床实践相结合——谈“中国急性心力衰竭急诊临床实践指南(2017)”撰写[J]. 中国急救医学, 2018, 38(1): 14-15.
6 何小军, 王 勇, 郭 伟. 日本呼吸病学协会无创正压通气指南(第二次修订版)[J]. 中华急诊医学杂志, 2017, 26(7): 735-738.
7 王建东, 周 平, 章晓红, 等. 呼吸浅快指数和气道闭合压对严重创伤患者撤机的预测价值[J]. 西部医学, 2015, 27(11): 1705-1707.
8 雷清梅, 王闪闪, 成金妹, 等. 扰动系数在颅脑损伤患者脑水肿监测中的应用价值[J]. 重庆医学, 2018, 47(13): 1737-1739.
9 金 巍, 徐靖华, 刘建光, 等. 舒利迭无创通气对慢性阻塞性肺疾病合并呼吸衰竭患者肺功能及动脉血气分析的影响[J]. 现代生物医学进展, 2016, 16(26): 5085-5087.
10 矫伟克. 有创-无创序贯通气治疗农药中毒(急性)并呼吸衰竭的应用观察[J]. 事件最新医学信息文摘, 2017, 14(7): 12-13.
11 黄 海, 刘 娟. 不同切换点行序贯通气治疗慢阻肺并呼吸衰竭的疗效比较[J]. 临床肺科杂志, 2016, 46(8): 1126-1127.
12 杨洪涛, 孙叔清, 徐延峰, 等. 有创-无创序贯通气治疗肺心病呼吸衰竭危重患者的效果及对相关指标的影响[J]. 疑难病杂志, 2018, 17(6): 558-561.
13 王 聪. 不同通气法对COPD并呼吸衰竭患者的疗效及预后研究[J]. 陕西医学杂志, 2017, 46(8): 1048-1049.
14 何焱志, 李艳娟. 机械通气撤机后序贯经鼻持续气道正压通气高流量鼻导管湿化氧疗在新生儿肺炎合并呼吸衰竭治疗中的疗效差异[J]. 河北医学, 2020, 26(7): 1148-1152.
15 曾 勉, 何婉媚. 呼吸机相关酸碱平衡的发病机制及处理对策[J]. 中华结核和呼吸杂志, 2014, 37(5): 398-400.
16 郭 龙, 张春媚, 高 勇, 等. ARDS发病机制的相关信号通路研究进展[J]. 中国实验诊断学, 2017, 21(9): 1647-1650.
17 李 妍, 韩锋锋. 外源性变应性肺泡炎发病机制研究进展[J]. 临床肺科杂志, 2014, 19(11): 2068-2070.
18 Quelch DR, Mick I, McGonigle J, et al. Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study[J]. Biol Psychiatry, 2017, 81(11): 941-948.
16 孙振康, 刘 成, 李东风, 等. HFNC与NPPV对老年呼吸衰竭患者机械通气拔管后低氧血症的疗效对比[J]. 中国老年学杂志, 2020, 40(19): 4109-4112.
20 黄 奎, 温小琴, 任 宁, 等. 左西孟旦在急性呼吸衰竭合并心力衰竭患者二次脱离机械通气中的应用[J]. 山东医药, 2020, 60(23): 48-50.
21 周 莉, 江 涛, 廖晓华, 等. 通腑泄肺法在急性呼吸衰竭有创机械通气中的应用[J]. 中国中医急症, 2020, 29(5): 887-890.
22 梁丽萍, 黄炎明, 陈美玲, 等. 高流量鼻腔氧疗与无创机械通气在病毒性肺炎所致呼吸衰竭患者中的疗效比较[J]. 临床内科杂志, 2020, 37(6): 419-422.
23 许 凯, 章福彬, 韦 兵. 以RPFIW为切换点行序贯通气联治疗COPD合并呼吸衰竭的疗效观察[J]. 浙江临床医学, 2016, 18(7): 1273-1274.
24 王 莉, 成晓蓉, 杨海燕, 等. 序贯经鼻高流量通气在急诊重症呼吸衰竭患者护理工作中的应用效果观察[J]. 长春中医药大学学报, 2020, 36(5): 1027-1030.

备注/Memo

备注/Memo:
基金项目: 东莞市社会科技发展(一般)项目(2018507150401444)
更新日期/Last Update: 2020-12-20